Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia

Clinical Endocrinology

Volumn 78, Issue 2, 2013, Pages 197-203

  Han, T S ^a   Stimson, R H ^b   Rees, D A ^c   Krone, N ^d   Willis, D S ^e   Conway, G S ^a   Arlt, W ^d   Walker, B R ^b   Ross, R J ^f  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e Society for Endocrinology   (United Kingdom)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROGESTERONE; PREDNISOLONE; TESTOSTERONE;

ADULT; ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MUTATION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; CROSS-SECTIONAL STUDIES; DEXAMETHASONE; DRUG THERAPY, COMBINATION; ENERGY METABOLISM; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84872112438     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12045     Document Type: Article

References (27)

1. Arlt, W., Willis, D.S., Wild, S.H., et al,.; United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE) (2010) Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. Journal of Clinical Endocrinology and Metabolism, 95, 5110-5121.
2. Walker, B.R., (2007) Glucocorticoids and cardiovascular disease. European Journal of Endocrinology, 157, 545-559.
3. Merke, D.P., &, Bornstein, S.R., (2005) Congenital adrenal hyperplasia. Lancet, 365, 2125-2136.
4. Speiser, P.W., Azziz, R., Baskin, L.S., et al,. (2010) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 95, 4133-4160.
5. Merke, D.P., (2008) Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 93, 653-660.
6. Compston, J., (2004) US and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differences. Current Rheumatology Reports, 6, 66-69.
7. British Medical Association and Royal Pharmaceutical Society (2012) British National Formulary (BNF 63). British Medical Journal Publishing Group and Pharmaceutical Press, London.
8. Rivkees, S.A., &, Crawford, J.D., (2000) Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics, 106, 767-773.
9. Arlt, W., (2009) The approach to the adult with newly diagnosed adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism, 94, 1059-1067.
10. Punthakee, Z., Legault, L., &, Polychronakos, C., (2003) Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. The Journal of pediatrics, 143, 402-405.
11. Bonfig, W., Bechtold, S., Schmidt, H., et al,. (2007) Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. Journal of Clinical Endocrinology and Metabolism, 92, 1635-1639.
12. Krieger, D.T., Allen, W., Rizzo, F., et al,. (1971) Characterization of the normal temporal pattern of plasma corticosteroid levels. Journal of Clinical Endocrinology and Metabolism, 32, 266-284.
13. Debono, M., Ghobadi, C., Rostami-Hodjegan, A., et al,. (2009) Modified-release hydrocortisone to provide circadian cortisol profiles. Journal of Clinical Endocrinology and Metabolism, 94, 1548-1554.
14. Mah, P.M., Jenkins, R.C., Rostami-Hodjegan, A., et al,. (2004) Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clinical Endocrinology, 61, 367-375.
15. Verma, S., Vanryzin, C., Sinaii, N., et al,. (2010) A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clinical Endocrinology, 72, 441-447.
16. Plat, L., Leproult, R., L'Hermite-Baleriaux, M., et al,. (1999) et al Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. Journal of Clinical Endocrinology and Metabolism, 84, 3082-3092.
17. Elbelt, U., Hahner, S., &, Allolio, B., (2009) Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy. European Journal of Endocrinology, 160, 919-924.
18. Spiegel, K., Leproult, R., &, Van Cauter, E., (1999) Impact of sleep debt on metabolic and endocrine function. Lancet, 354, 1435-1439.
19. Speiser, P.W., Dupont, J., Zhu, D., et al,. (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The Journal of Clinical Investigation, 90, 584-595.
20. Wedell, A., Thilen, A., Ritzen, E.M., et al,. (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. Journal of Clinical Endocrinology and Metabolism, 78, 1145-1152.
21. Krone, N., Braun, A., Roscher, A.A., et al,. (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. Journal of Clinical Endocrinology and Metabolism, 85, 1059-1065.
22. Armitage, P., Berry, G., &, Matthews, J.N.S., (2002) Statistical Methods in Medical Research, 4th edn. Blackwell Science, Oxford, UK.
23. Kaiser, H.F., (1960) The application of electronic computers to factor analysis. Educational and Psychological Measurement, 20, 141-151.
24. Cattell, R.B., (1966) The scree test for the number of factors. Multivariate Behavioral Research, 1, 629-637.
25. Stanworth, R.D., Kapoor, D., Channer, K.S., et al,. (2011) Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes. Clinical Endocrinology 74, 624-630.
26. ' Ten, S., New, M., &, Maclaren, N., (2001) Clinical review 130: Addison's disease. Journal of Clinical Endocrinology and Metabolism 86, 2909-2922.
27. Merza, Z., Rostami-Hodjegan, A., Memmott, A., et al,. (2006) Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clinical Endocrinology 65, 45-50.